{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:39:22Z","timestamp":1766983162434},"publisher-location":"Boston, MA","reference-count":17,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781475792119"},{"type":"electronic","value":"9781475792096"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996]]},"DOI":"10.1007\/978-1-4757-9209-6_27","type":"book-chapter","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T08:11:56Z","timestamp":1367827916000},"page":"299-304","source":"Crossref","is-referenced-by-count":15,"title":["Current Clinical Experience with Nevirapine for HIV Infection"],"prefix":"10.1007","author":[{"given":"Andrew","family":"Carr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"27_CR1","doi-asserted-by":"crossref","unstructured":"Merluzzi VJ. Hargrave KD, Labadia M. Inhibition of HIV-1 replication by a nonnucleoside reverse transcriptase inhibitor. Science 1990;. 250; 1411\u20133.","DOI":"10.1126\/science.1701568"},{"key":"27_CR2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/infdis\/163.5.966","volume":"163","author":"RA Koup","year":"1991","unstructured":"Koup RA, Merluzzi VJ, Hargrave KD, et al. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by the dipyridodiazepinone BI-RG-587. J Infect Dis 1991; 163: 966\u201370.","journal-title":"J Infect Dis"},{"key":"27_CR3","unstructured":"Nevirapine Investigator\u2019s Brochure. Boerhinger-Ingelheim Pharmaceuticals Inc. 1994."},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"11241","DOI":"10.1073\/pnas.88.24.11241","volume":"88","author":"D Richman","year":"1991","unstructured":"Richman D, Shill CK, Lowy I, et al. Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture. Proc Natl Acad Sci USA 1991, 88: 11241\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"27_CR5","first-page":"446","volume":"41","author":"JW Mellors","year":"1992","unstructured":"Mellors JW, Dutschman GE, Im GJ, et al. In vitro selection and molecular characterisation of human immunodeficiency virus-1 resistant to nonnucleoside inhibitors of reverse transcriptase. Mol Pharmacol 1992; 41: 446\u201351.","journal-title":"Mol Pharmacol"},{"key":"27_CR6","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1128\/JVI.65.9.4887-4892.1991","volume":"65","author":"J Nunberg","year":"1991","unstructured":"Nunberg J14, Schleif WA, Boots EJ, et al. Viral resistance to human immunodeficiency virus type-lspecific pyridinone reverse transcriptase inhibitors. J Virol 1991; 65: 4887\u201392.","journal-title":"J Virol"},{"key":"27_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1128\/AAC.35.2.305","volume":"35","author":"D Richman","year":"1991","unstructured":"Richman D, Rosenthal AS, Skoog M, et al. BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine. Antimicrob Agents Chemother 1991, 35; 305\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"27_CR8","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/JVI.68.3.1660-1666.1994","volume":"68","author":"DD Richman","year":"1994","unstructured":"Richman DD, Havlir D, Corbeil. Nevirapine resistance mutations of human immunodeficiency virus (HIV) type 1 selected during therapy. J Virol 1994; 68: 1660\u20136.","journal-title":"J Virol"},{"key":"27_CR9","first-page":"141","volume":"8","author":"SH Cheeseman","year":"1995","unstructured":"Cheeseman SH. Havlir D. McLaughlin MM, et al. Phase I\/1I evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immun Defic Syndrom Related Retrovir 1995; 8: 141\u201351.","journal-title":"J Acquir Immun Defic Syndrom Related Retrovir"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/infdis\/171.3.537","volume":"171","author":"D Havlir","year":"1995","unstructured":"Havlir D, Cheeseman SH, McLaughlin M, et al. High-dose nevirapine: safety, pharmacokinetics and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis 1995; 171: 537\u201345.","journal-title":"J Infect Dis"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1128\/AAC.36.12.2664","volume":"36","author":"BA Larder","year":"1992","unstructured":"Larder BA. 3\u2019-azido-3\u2019-deoxythymidine resistance suppressed by a mutation conferring human immunodefiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 1992; 36: 2664\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"27_CR12","first-page":"26","volume-title":"Nevirapine resistance during clinical trials (abstract). In","author":"DD Richman","year":"1993","unstructured":"Richman DD. Nevirapine resistance during clinical trials (abstract). In: Abstracts of the Second International Workshop on HIV Drug Resistance; Noordwijk, June 1993: 26."},{"key":"27_CR13","first-page":"250","volume":"97","author":"E Vasak A","year":"1994","unstructured":"Carr A Vasak E, Munro V, Penny R, Cooper DA. Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection. Clin Exp Immunol 1994; 97: 250\u20133.","journal-title":"Clin Exp Immunol"},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1093\/infdis\/169.6.1346","volume":"169","author":"MD Jong","year":"1994","unstructured":"de Jong MD, Loewenthal M, Boucher CAB, et al. Alternating nevirapine and zidovudine treatment of human immunodeficiency virus type 1-infected persons does not prolong nevirapine activity. J Infect Dis 1994; 169: 1346\u201350.","journal-title":"J Infect Dis"},{"key":"27_CR15","unstructured":"de Jong M, and the Dutch-Italian-Australian Nevirapine Study Group. Antiviral response to nevirapine monotherapy in nucleoside naive persons. In: Abstracts of the 10th International Conference on AIDS, Yokohama, Japan, August, 1994; Abstract PB0847."},{"key":"27_CR16","unstructured":"Can A, and the Australian-Italian-Dutch Nevirapine Study Group. Efficacy of nevirapinn added to zidovudine in p24-positive HIV-1-infected patients with CD4+ counts less than 500\/nun. In: Abstracts of the 10th International Conference on AIDS, Yokohama, Japan, August, 1994; Abstract 511B."},{"key":"27_CR17","unstructured":"Fischi MA. Efficacy and toxicities of combination antiretroviral therapies. In: Program of the 2nd International Congress on Drug Therapy of HIV Infection, Glasgow, United Kingdom, November, 1994: Abstract 7. 2."}],"container-title":["Advances in Experimental Medicine and Biology","Antiviral Chemotherapy 4"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4757-9209-6_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,26]],"date-time":"2020-07-26T10:18:35Z","timestamp":1595758715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4757-9209-6_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"ISBN":["9781475792119","9781475792096"],"references-count":17,"URL":"https:\/\/doi.org\/10.1007\/978-1-4757-9209-6_27","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1996]]}}}